Updated and expanded guidance will help pharmaceutical companies maximize testing efficiency of computerized and software-based systems that impact patient safety, product quality and data integrity.
(PRWeb January 16, 2013)
Read the full story at http://www.prweb.com/releases/2013/1/prweb10331270.htm